Royal Bank Of Canada Coll Plant Biotechnologies LTD Transaction History
Royal Bank Of Canada
- $458 Billion
- Q1 2025
A detailed history of Royal Bank Of Canada transactions in Coll Plant Biotechnologies LTD stock. As of the latest transaction made, Royal Bank Of Canada holds 500 shares of CLGN stock, worth $695. This represents 0.0% of its overall portfolio holdings.
Number of Shares
500Holding current value
$695% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CLGN
# of Institutions
19Shares Held
2.07MCall Options Held
0Put Options Held
0-
Pinnacle Associates LTD489KShares$679,9780.02% of portfolio
-
Villere St Denis J & CO LLC484KShares$672,5750.13% of portfolio
-
Investment Management Of Virginia LLC464KShares$644,8190.63% of portfolio
-
Roumell Asset Management, LLC Chevy Chase, MD276KShares$384,2372.69% of portfolio
-
Amh Equity LTD125KShares$173,7500.52% of portfolio
About CollPlant Biotechnologies Ltd
- Ticker CLGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,086,500
- Market Cap $15.4M
- Description
- CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering tech...